It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Early pre-60S ribosomal particles are poorly characterized, highly dynamic complexes that undergo extensive rRNA folding and compaction concomitant with assembly of ribosomal proteins and exchange of assembly factors. Pre-60S particles contain numerous RNA helicases, which are likely regulators of accurate and efficient formation of appropriate rRNA structures. Here we reveal binding of the RNA helicase Dbp7 to domain V/VI of early pre-60S particles in yeast and show that in the absence of this protein, dissociation of the Npa1 scaffolding complex, release of the snR190 folding chaperone, recruitment of the A3 cluster factors and binding of the ribosomal protein uL3 are impaired. uL3 is critical for formation of the peptidyltransferase center (PTC) and is responsible for stabilizing interactions between the 5′ and 3′ ends of the 25S, an essential pre-requisite for subsequent pre-60S maturation events. Highlighting the importance of pre-ribosome remodeling by Dbp7, our data suggest that in the absence of Dbp7 or its catalytic activity, early pre-ribosomal particles are targeted for degradation.
Early steps of large 60S ribosomal subunit biogenesis are not well understood. Here, the authors combine biochemical experiments with protein-RNA crosslinking and mass spectrometry to show that the RNA helicase Dbp7 is key player during early 60S ribosomal assembly. Dbp7 regulates a series of events driving compaction of domain V/VI in early pre60S ribosomal particles.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University Medical Center Göttingen, Department of Molecular Biology, Göttingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331)
2 University of Copenhagen, Department of Cellular and Molecular Medicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)
3 Max Planck Institute for Biophysical Chemistry, Bioanalytical Mass Spectrometry, Göttingen, Germany (GRID:grid.418140.8) (ISNI:0000 0001 2104 4211); Johann Wolfgang Goethe University, Hematology/Oncology, Department of Medicine II, Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Frankfurt Cancer Institute, Goethe University, Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
4 Université de Toulouse, CNRS, UPS, Molecular, Cellular and Developmental Biology Unit (MCD), Centre de Biologie Intégrative (CBI), Toulouse, France (GRID:grid.15781.3a) (ISNI:0000 0001 0723 035X)
5 University of Copenhagen, Department of Cellular and Molecular Medicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Nord University, Genomics Group, Faculty of Biosciences and Aquaculture, Bodø, Norway (GRID:grid.465487.c)
6 Max Planck Institute for Biophysical Chemistry, Bioanalytical Mass Spectrometry, Göttingen, Germany (GRID:grid.418140.8) (ISNI:0000 0001 2104 4211); University Medical Center Göttingen, Institute for Clinical Chemistry, Göttingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331)
7 University Medical Center Göttingen, Department of Molecular Biology, Göttingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331); Georg-August-University, Göttingen Centre for Molecular Biosciences, Göttingen, Germany (GRID:grid.7450.6) (ISNI:0000 0001 2364 4210)